Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2025
Option Care Health (Nasdaq: OPCH), the largest independent provider of home and alternate site infusion services, reported strong Q2 2025 financial results. The company achieved net revenue of $1.42 billion, up 15.4% year-over-year, with net income of $50.5 million.
Key financial metrics include gross profit of $269.0 million (19.0% of revenue), Adjusted EBITDA of $114.0 million (up 5.2%), and diluted EPS of $0.31. The company repurchased approximately $50.0 million of stock during Q2.
Option Care Health updated its FY2025 guidance, projecting revenue of $5.50-5.65 billion, adjusted EPS of $1.65-1.72, and adjusted EBITDA of $465-475 million. The company expects cash flow from operations of at least $320 million.
Option Care Health (Nasdaq: OPCH), il principale fornitore indipendente di servizi di infusione a domicilio e in siti alternativi, ha riportato solidi risultati finanziari per il secondo trimestre 2025. L'azienda ha raggiunto un ricavo netto di 1,42 miliardi di dollari, in crescita del 15,4% rispetto all'anno precedente, con un utile netto di 50,5 milioni di dollari.
I principali indicatori finanziari includono un utile lordo di 269,0 milioni di dollari (19,0% dei ricavi), un EBITDA rettificato di 114,0 milioni di dollari (in aumento del 5,2%) e un utile per azione diluito di 0,31 dollari. Durante il secondo trimestre, l'azienda ha riacquistato azioni per un valore di circa 50,0 milioni di dollari.
Option Care Health ha aggiornato le previsioni per l'anno fiscale 2025, prevedendo ricavi tra 5,50 e 5,65 miliardi di dollari, un utile per azione rettificato tra 1,65 e 1,72 dollari e un EBITDA rettificato tra 465 e 475 milioni di dollari. L'azienda si attende un flusso di cassa operativo di almeno 320 milioni di dollari.
Option Care Health (Nasdaq: OPCH), el mayor proveedor independiente de servicios de infusi贸n en el hogar y en sitios alternativos, report贸 s贸lidos resultados financieros para el segundo trimestre de 2025. La compa帽铆a alcanz贸 ingresos netos de $1.42 mil millones, un aumento del 15.4% interanual, con un ingreso neto de $50.5 millones.
Los principales indicadores financieros incluyen un beneficio bruto de $269.0 millones (19.0% de los ingresos), un EBITDA ajustado de $114.0 millones (aumento del 5.2%) y un EPS diluido de $0.31. La compa帽铆a recompr贸 aproximadamente $50.0 millones en acciones durante el segundo trimestre.
Option Care Health actualiz贸 sus previsiones para el a帽o fiscal 2025, proyectando ingresos de $5.50-5.65 mil millones, un EPS ajustado de $1.65-1.72 y un EBITDA ajustado de $465-475 millones. La empresa espera un flujo de caja operativo de al menos $320 millones.
Option Care Health (雮橃姢雼�: OPCH)電� 臧�鞝� 氚� 雽�觳� 鞛レ唽 欤检瀰 靹滊箘鞀� 攵勳暭鞐愳劀 臧�鞛� 韥� 霃呺 鞝滉车鞐呾泊搿�, 2025雲� 2攵勱赴 臧曤牓頃� 鞛 鞁れ爜鞚� 氤搓碃頄堨姷雼堧嫟. 須岇偓電� 靾滊Г於� 14鞏� 2觳滊 雼煬毳� 雼劚頄堨溂氅�, 鞝勲厔 雽�牍� 15.4% 歃濌皜頄堦碃, 靾滌澊鞚� 5,050毵� 雼煬毳� 旮半頄堨姷雼堧嫟.
欤检殧 鞛 歆�響滊電� 毵れ稖齑濎澊鞚� 2鞏� 6,900毵� 雼煬 (毵れ稖鞚� 19.0%), 臁办爼 EBITDA 1鞏� 1,400毵� 雼煬 (5.2% 歃濌皜), 攴鸽Μ瓿� 頋劃 欤茧嫻靾滌澊鞚� 0.31雼煬臧� 韽暔霅╇媹雼�. 須岇偓電� 2攵勱赴 霃欖晥 鞎� 5,000毵� 雼煬 攴滊鞚� 鞛愳偓欤茧ゼ 毵れ瀰頄堨姷雼堧嫟.
Option Care Health電� 2025 須岅硠鞐半弰 臧�鞚措崢鞀るゼ 鞐呺嵃鞚错姼頃橃棳 毵れ稖 55鞏祣56鞏� 5觳滊 雼煬, 臁办爼 欤茧嫻靾滌澊鞚� 1.65~1.72雼煬, 臁办爼 EBITDA 4鞏� 6,500毵寏4鞏� 7,500毵� 雼煬毳� 鞓堨儊頃橁碃 鞛堨姷雼堧嫟. 霕愴暅 斓滌唽 3鞏� 2觳滊 雼煬鞚� 鞓侅梾 順勱笀 頋愲鞚� 旮半寑頃橁碃 鞛堨姷雼堧嫟.
Option Care Health (Nasdaq : OPCH), le plus grand fournisseur ind茅pendant de services de perfusion 脿 domicile et sur sites alternatifs, a annonc茅 de solides r茅sultats financiers pour le deuxi猫me trimestre 2025. La soci茅t茅 a r茅alis茅 un chiffre d'affaires net de 1,42 milliard de dollars, en hausse de 15,4 % sur un an, avec un b茅n茅fice net de 50,5 millions de dollars.
Les principaux indicateurs financiers comprennent un profit brut de 269,0 millions de dollars (19,0 % du chiffre d'affaires), un EBITDA ajust茅 de 114,0 millions de dollars (en hausse de 5,2 %) et un b茅n茅fice par action dilu茅 de 0,31 dollar. La soci茅t茅 a rachet茅 environ 50,0 millions de dollars d'actions au cours du deuxi猫me trimestre.
Option Care Health a mis 脿 jour ses pr茅visions pour l'exercice 2025, pr茅voyant un chiffre d'affaires compris entre 5,50 et 5,65 milliards de dollars, un BPA ajust茅 entre 1,65 et 1,72 dollar, et un EBITDA ajust茅 entre 465 et 475 millions de dollars. La soci茅t茅 s'attend 脿 un flux de tr茅sorerie provenant des op茅rations d'au moins 320 millions de dollars.
Option Care Health (Nasdaq: OPCH), der gr枚脽te unabh盲ngige Anbieter von Infusionsdiensten zu Hause und an alternativen Standorten, meldete starke Finanzergebnisse f眉r das zweite Quartal 2025. Das Unternehmen erzielte einen Nettoerl枚s von 1,42 Milliarden US-Dollar, was einem Anstieg von 15,4 % im Jahresvergleich entspricht, sowie einen Nettoertrag von 50,5 Millionen US-Dollar.
Wichtige Finanzkennzahlen umfassen einen Bruttogewinn von 269,0 Millionen US-Dollar (19,0 % des Umsatzes), ein bereinigtes EBITDA von 114,0 Millionen US-Dollar (plus 5,2 %) und ein verw盲ssertes Ergebnis je Aktie von 0,31 US-Dollar. Das Unternehmen kaufte im zweiten Quartal Aktien im Wert von etwa 50,0 Millionen US-Dollar zur眉ck.
Option Care Health aktualisierte seine Prognose f眉r das Gesch盲ftsjahr 2025 und erwartet Ums盲tze von 5,50 bis 5,65 Milliarden US-Dollar, ein bereinigtes Ergebnis je Aktie von 1,65 bis 1,72 US-Dollar und ein bereinigtes EBITDA von 465 bis 475 Millionen US-Dollar. Das Unternehmen rechnet mit einem operativen Cashflow von mindestens 320 Millionen US-Dollar.
- Revenue growth of 15.4% year-over-year to $1.42 billion
- Adjusted EBITDA increased 5.2% to $114.0 million
- Adjusted EPS grew 10.8% to $0.41
- $50.0 million in stock repurchases completed
- Strong operating cash flow of $90.3 million
- Gross profit margin declined to 19.0% from 20.3% year-over-year
- Net income decreased to $50.5 million from $53.0 million in Q2 2024
- Operating cash flow decreased significantly from $195.7 million in Q2 2024
- Interest expense increased to $14.4 million from $12.6 million year-over-year
Insights
Option Care Health posted 15.4% revenue growth but lower margins with mixed performance metrics in Q2 2025, maintaining positive financial trajectory.
Option Care Health delivered a 15.4% revenue increase in Q2 2025, reaching
The company's net income declined slightly to
Despite these mixed signals, adjusted EPS increased
Management's updated 2025 guidance suggests continued confidence in business performance, forecasting full-year revenue between
BANNOCKBURN, Ill., July 30, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the 鈥淐ompany鈥� or 鈥淥ption Care Health鈥�) (Nasdaq: OPCH), the nation鈥檚 largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June听30, 2025.
Second Quarter 2025 Financial Highlights
- Net revenue of
$1,416.1 million , up15.4% compared to$1,227.2 million in the second quarter of 2024 - Gross profit of
$269.0 million , or19.0% of net revenue, up7.9% compared to$249.4 million , or20.3% of net revenue, in the second quarter of 2024 - Net income of
$50.5 million , compared to net income of$53.0 million , in the second quarter of 2024 and diluted earnings per share of$0.31 , up3.3% compared to diluted earnings per share of$0.30 in the second quarter of 2024 - Adjusted net income of
$67.5 million , compared to adjusted net income of$64.9 million , in the second quarter of 2024 and adjusted diluted earnings per share of$0.41 , up10.8% compared to adjusted diluted earnings per share of$0.37 in the second quarter of 2024 - Adjusted EBITDA of
$114.0 million , up5.2% compared to$108.4 million in the second quarter of 2024 - Cash provided by operating activities of
$90.3 million , compared to cash provided by operating activities of$195.7 million in the second quarter of 2024 - Repurchased approximately
$50.0 million of stock in the second quarter of 2025
John C. Rademacher, Chief Executive Officer, commented, 鈥淚 am proud of the second quarter performance and the Option Care Health team's ability to show resilience in a dynamic marketplace. We continue to execute on opportunities to provide strong clinical outcomes while helping reduce the total cost of care.鈥�
Updated Full Year 2025 Financial Guidance
For the full year 2025, Option Care Health now expects to generate:
- Net revenue of
$5.50听产颈濒濒颈辞苍 to$5.65听产颈濒濒颈辞苍 - Adjusted diluted earnings per share of
$1.65 t o$1.72 - Adjusted EBITDA of
$465听尘颈濒濒颈辞苍 to$475听尘颈濒濒颈辞苍 - Cash flow from operations of at least
$320听尘颈濒濒颈辞苍 - Effective tax rate of
25% -27% - Net interest expense of approximately
$55听尘颈濒濒颈辞苍 to$60听尘颈濒濒颈辞苍
Conference Call
Option Care Health will host a conference call to discuss its second quarter 2025 financial results later today at 8:30 a.m. ET. The conference call can be accessed via a live audio webcast that will be available online at . A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.
About Option Care Health
Option Care Health is the nation鈥檚 largest independent provider of home and alternate site infusion services. With over 8,000 team members including more than 5,000 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn more, please visit our website at .
Investor Contact
Mike Shapiro
Chief Financial Officer
T:听 (312) 940-2538
Forward-Looking Statements - Safe Harbor
This press release may contain 鈥渇orward-looking statements鈥� within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: 鈥渁nticipate,鈥� 鈥渋ntend,鈥� 鈥減lan,鈥� 鈥渂elieve,鈥� 鈥減roject,鈥� 鈥渆stimate,鈥� 鈥渆xpect,鈥� 鈥渕ay,鈥� 鈥渟hould,鈥� 鈥渨ill鈥� and similar references to future periods. Examples of forward-looking statements include, among others, statements we may make regarding future revenues, future earnings, regulatory developments, market developments, new products and growth strategies, integration activities and the effects of any of the foregoing on our future results of operations or financial conditions.
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: changes in laws and regulations applicable to our business model; changes in market conditions and receptivity to our services and offerings; pending and future litigation; potential liability for claims not covered by insurance; and loss of relationships with managed care organizations and other non-governmental third party payers. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our periodic reports as filed with the SEC.
Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
Note Regarding Use of Non-GAAP Financial Measures
In addition to reporting financial information in accordance with generally accepted accounting principles (GAAP), the Company is also reporting Adjusted net income, Adjusted EBITDA and Adjusted earnings per share ("Adjusted EPS"), which are non-GAAP financial measures. These adjusted measures are not measurements of financial performance under GAAP and should not be used in isolation or as a substitute or alternative to net income, earnings per share, or any other performance measure derived in accordance with GAAP, or as a substitute or alternative to cash flow from operating activities or a measure of the Company鈥檚 liquidity. In addition, the Company's definitions of Adjusted net income, Adjusted EBITDA, and Adjusted EPS may not be comparable to similarly titled non-GAAP financial measures reported by other companies. As defined by the Company: (i) Adjusted net income represents net income before intangible asset amortization expense, stock-based compensation expense, and restructuring, acquisition, integration and other expenses, net of tax adjustments, (ii) Adjusted EBITDA represents net income before net interest expense, income tax expense, depreciation and amortization, stock-based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other expenses, and (iii) Adjusted earnings per share represents Adjusted net income divided by weighted average common shares outstanding, diluted. As part of restructuring, acquisition, integration and other expenses, the Company may incur significant charges such as the write down of certain long鈥憀ived assets, temporary redundant expenses, professional fees, certain litigation expenses and reserves related to acquired businesses, potential retention and severance costs and potential accelerated payments or termination costs for certain of its contractual obligations. Management believes that these adjusted measures provide useful supplemental information regarding the performance of Option Care Health鈥檚 business operations and facilitate comparisons to the Company鈥檚 historical operating results. We have not reconciled Adjusted EBITDA or Adjusted diluted earnings per share guidance to net income as management believes creation of this reconciliation would not be practicable due to the uncertainty regarding, and potential variability of, material reconciling items. Full reconciliations of each adjusted measure to the most comparable GAAP financial measure are set forth below.
听听Schedule 1
| OPTION CARE HEALTH, INC. |
| CONDENSED CONSOLIDATED BALANCE SHEETS |
| (IN THOUSANDS)(UNAUDITED) |
| 听 |
| 听 | June 30, 2025 | 听 | December 31, 2024 | ||
| ASSETS | 听 | 听 | 听 | ||
| CURRENT ASSETS: | 听 | 听 | 听 | ||
| Cash and cash equivalents | $ | 198,818 | 听 | $ | 412,565 |
| Accounts receivable, net | 听 | 481,253 | 听 | 听 | 409,733 |
| Inventories | 听 | 403,542 | 听 | 听 | 388,131 |
| Prepaid expenses and other current assets | 听 | 91,616 | 听 | 听 | 112,198 |
| Total current assets | 听 | 1,175,229 | 听 | 听 | 1,322,627 |
| 听 | 听 | 听 | 听 | ||
| NONCURRENT ASSETS: | 听 | 听 | 听 | ||
| Property and equipment, net | 听 | 133,673 | 听 | 听 | 127,367 |
| Intangible assets, net | 听 | 23,566 | 听 | 听 | 16,993 |
| Referral sources, net | 听 | 304,151 | 听 | 听 | 284,017 |
| Goodwill | 听 | 1,605,855 | 听 | 听 | 1,540,246 |
| Other noncurrent assets | 听 | 140,352 | 听 | 听 | 130,493 |
| Total noncurrent assets | 听 | 2,207,597 | 听 | 听 | 2,099,116 |
| TOTAL ASSETS | $ | 3,382,826 | 听 | $ | 3,421,743 |
| 听 | 听 | 听 | 听 | ||
| LIABILITIES AND STOCKHOLDERS鈥� EQUITY | 听 | 听 | 听 | ||
| CURRENT LIABILITIES: | 听 | 听 | 听 | ||
| Accounts payable | $ | 590,221 | 听 | $ | 610,779 |
| Other current liabilities | 听 | 183,399 | 听 | 听 | 169,367 |
| Total current liabilities | 听 | 773,620 | 听 | 听 | 780,146 |
| 听 | 听 | 听 | 听 | ||
| NONCURRENT LIABILITIES: | 听 | 听 | 听 | ||
| Long-term debt, net of discount, deferred financing costs and current portion | 听 | 1,103,701 | 听 | 听 | 1,104,641 |
| Other noncurrent liabilities | 听 | 145,557 | 听 | 听 | 132,718 |
| Total noncurrent liabilities | 听 | 1,249,258 | 听 | 听 | 1,237,359 |
| Total liabilities | 听 | 2,022,878 | 听 | 听 | 2,017,505 |
| 听 | 听 | 听 | 听 | ||
| STOCKHOLDERS鈥� EQUITY | 听 | 1,359,948 | 听 | 听 | 1,404,238 |
| TOTAL LIABILITIES AND STOCKHOLDERS鈥� EQUITY | $ | 3,382,826 | 听 | $ | 3,421,743 |
| 听 | |||||
Schedule 2
| OPTION CARE HEALTH, INC. |
| CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS |
| (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)(UNAUDITED) |
| 听 |
| 听 | Three Months Ended June听30, | 听 | Six Months Ended June听30, | ||||||||||||
| 听 | 听 | 2025 | 听 | 听 | 听 | 2024 | 听 | 听 | 听 | 2025 | 听 | 听 | 听 | 2024 | 听 |
| NET REVENUE | $ | 1,416,085 | 听 | 听 | $ | 1,227,186 | 听 | 听 | $ | 2,749,057 | 听 | 听 | $ | 2,373,238 | 听 |
| COST OF REVENUE | 听 | 1,147,042 | 听 | 听 | 听 | 977,821 | 听 | 听 | 听 | 2,216,962 | 听 | 听 | 听 | 1,885,373 | 听 |
| GROSS PROFIT | 听 | 269,043 | 听 | 听 | 听 | 249,365 | 听 | 听 | 听 | 532,095 | 听 | 听 | 听 | 487,865 | 听 |
| 听 | 听 | 听 | 听 | 听 | 听 | 听 | 听 | ||||||||
| OPERATING COSTS AND EXPENSES: | 听 | 听 | 听 | 听 | 听 | 听 | 听 | ||||||||
| Selling, general and administrative expenses | 听 | 170,092 | 听 | 听 | 听 | 153,783 | 听 | 听 | 听 | 338,210 | 听 | 听 | 听 | 308,525 | 听 |
| Depreciation and amortization expense | 听 | 16,241 | 听 | 听 | 听 | 14,907 | 听 | 听 | 听 | 31,987 | 听 | 听 | 听 | 29,635 | 听 |
| Total operating expenses | 听 | 186,333 | 听 | 听 | 听 | 168,690 | 听 | 听 | 听 | 370,197 | 听 | 听 | 听 | 338,160 | 听 |
| OPERATING INCOME | 听 | 82,710 | 听 | 听 | 听 | 80,675 | 听 | 听 | 听 | 161,898 | 听 | 听 | 听 | 149,705 | 听 |
| 听 | 听 | 听 | 听 | 听 | 听 | 听 | 听 | ||||||||
| OTHER INCOME (EXPENSE): | 听 | 听 | 听 | 听 | 听 | 听 | 听 | ||||||||
| Interest expense, net | 听 | (14,447 | ) | 听 | 听 | (12,603 | ) | 听 | 听 | (27,678 | ) | 听 | 听 | (25,805 | ) |
| Other, net | 听 | 598 | 听 | 听 | 听 | 3,969 | 听 | 听 | 听 | (1,803 | ) | 听 | 听 | 5,096 | 听 |
| Total other expense | 听 | (13,849 | ) | 听 | 听 | (8,634 | ) | 听 | 听 | (29,481 | ) | 听 | 听 | (20,709 | ) |
| 听 | 听 | 听 | 听 | 听 | 听 | 听 | 听 | ||||||||
| INCOME BEFORE INCOME TAXES | 听 | 68,861 | 听 | 听 | 听 | 72,041 | 听 | 听 | 听 | 132,417 | 听 | 听 | 听 | 128,996 | 听 |
| INCOME TAX EXPENSE | 听 | 18,338 | 听 | 听 | 听 | 18,998 | 听 | 听 | 听 | 35,152 | 听 | 听 | 听 | 31,162 | 听 |
| NET INCOME | $ | 50,523 | 听 | 听 | $ | 53,043 | 听 | 听 | $ | 97,265 | 听 | 听 | $ | 97,834 | 听 |
| 听 | 听 | 听 | 听 | 听 | 听 | 听 | 听 | ||||||||
| Earnings per share, basic | $ | 0.31 | 听 | 听 | $ | 0.31 | 听 | 听 | $ | 0.59 | 听 | 听 | $ | 0.56 | 听 |
| Earnings per share, diluted | $ | 0.31 | 听 | 听 | $ | 0.30 | 听 | 听 | $ | 0.59 | 听 | 听 | $ | 0.56 | 听 |
| 听 | 听 | 听 | 听 | 听 | 听 | 听 | 听 | ||||||||
| Weighted average common shares outstanding, basic | 听 | 162,931 | 听 | 听 | 听 | 172,927 | 听 | 听 | 听 | 164,188 | 听 | 听 | 听 | 173,428 | 听 |
| Weighted average common shares outstanding, diluted | 听 | 164,133 | 听 | 听 | 听 | 174,090 | 听 | 听 | 听 | 165,402 | 听 | 听 | 听 | 174,831 | 听 |
| 听 | |||||||||||||||
Schedule 3
| OPTION CARE HEALTH, INC. |
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
| (IN THOUSANDS)(UNAUDITED) |
| 听 |
| 听 | Six Months Ended June听30, | ||||||
| 听 | 听 | 2025 | 听 | 听 | 听 | 2024 | 听 |
| CASH FLOWS FROM OPERATING ACTIVITIES: | 听 | 听 | 听 | ||||
| Net income | $ | 97,265 | 听 | 听 | $ | 97,834 | 听 |
| Adjustments to reconcile net income to net cash provided by operations: | 听 | 听 | 听 | ||||
| Depreciation and amortization expense | 听 | 33,326 | 听 | 听 | 听 | 30,802 | 听 |
| Other adjustments | 听 | 35,857 | 听 | 听 | 听 | 38,874 | 听 |
| Changes in operating assets and liabilities: | 听 | 听 | 听 | ||||
| Accounts receivable, net | 听 | (61,392 | ) | 听 | 听 | (90,642 | ) |
| Inventories | 听 | (12,718 | ) | 听 | 听 | (7,417 | ) |
| Prepaid expenses and other current assets | 听 | 17,606 | 听 | 听 | 听 | (1,745 | ) |
| Accounts payable | 听 | (27,904 | ) | 听 | 听 | 107,558 | 听 |
| Accrued compensation and employee benefits | 听 | 8,730 | 听 | 听 | 听 | (30,206 | ) |
| Other | 听 | (7,651 | ) | 听 | 听 | (18,187 | ) |
| Net cash provided by operating activities | 听 | 83,119 | 听 | 听 | 听 | 126,871 | 听 |
| 听 | 听 | 听 | 听 | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | 听 | 听 | 听 | ||||
| Acquisition of property and equipment | 听 | (18,466 | ) | 听 | 听 | (15,597 | ) |
| Business acquisitions, net of cash acquired | 听 | (117,247 | ) | 听 | 听 | 鈥� | 听 |
| Net cash used in investing activities | 听 | (135,713 | ) | 听 | 听 | (15,597 | ) |
| 听 | 听 | 听 | 听 | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | 听 | 听 | 听 | ||||
| Purchase of company stock and related excise taxes | 听 | (152,429 | ) | 听 | 听 | (118,122 | ) |
| Proceeds from issuance of debt | 听 | 鈥� | 听 | 听 | 听 | 49,959 | 听 |
| Other financing activities | 听 | (8,724 | ) | 听 | 听 | (10,088 | ) |
| Net cash used in financing activities | 听 | (161,153 | ) | 听 | 听 | (78,251 | ) |
| 听 | 听 | 听 | 听 | ||||
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS | 听 | (213,747 | ) | 听 | 听 | 33,023 | 听 |
| Cash and cash equivalents - beginning of the period | 听 | 412,565 | 听 | 听 | 听 | 343,849 | 听 |
| CASH AND CASH EQUIVALENTS - END OF PERIOD | $ | 198,818 | 听 | 听 | $ | 376,872 | 听 |
| 听 | |||||||
Schedule 4
| OPTION CARE HEALTH, INC. |
| QUARTERLY RECONCILIATION BETWEEN GAAP AND NON-GAAP MEASURES |
| (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)(UNAUDITED) |
| 听 |
| 听 | Three Months Ended June听30, | 听 | Six Months Ended June听30, | ||||||||||||
| 听 | 听 | 2025 | 听 | 听 | 听 | 2024 | 听 | 听 | 听 | 2025 | 听 | 听 | 听 | 2024 | 听 |
| Net income | $ | 50,523 | 听 | 听 | $ | 53,043 | 听 | 听 | $ | 97,265 | 听 | 听 | $ | 97,834 | 听 |
| Interest expense, net | 听 | 14,447 | 听 | 听 | 听 | 12,603 | 听 | 听 | 听 | 27,678 | 听 | 听 | 听 | 25,805 | 听 |
| Income tax expense | 听 | 18,338 | 听 | 听 | 听 | 18,998 | 听 | 听 | 听 | 35,152 | 听 | 听 | 听 | 31,162 | 听 |
| Depreciation and amortization expense | 听 | 16,953 | 听 | 听 | 听 | 15,497 | 听 | 听 | 听 | 33,326 | 听 | 听 | 听 | 30,802 | 听 |
| EBITDA | 听 | 100,261 | 听 | 听 | 听 | 100,141 | 听 | 听 | 听 | 193,421 | 听 | 听 | 听 | 185,603 | 听 |
| 听 | 听 | 听 | 听 | 听 | 听 | 听 | 听 | ||||||||
| EBITDA adjustments | 听 | 听 | 听 | 听 | 听 | 听 | 听 | ||||||||
| Stock-based incentive compensation expense | 听 | 10,712 | 听 | 听 | 听 | 7,608 | 听 | 听 | 听 | 19,513 | 听 | 听 | 听 | 17,213 | 听 |
| Loss on extinguishment of debt | 听 | 鈥� | 听 | 听 | 听 | 377 | 听 | 听 | 听 | 鈥� | 听 | 听 | 听 | 377 | 听 |
| Restructuring, acquisition, integration and other | 听 | 3,045 | 听 | 听 | 听 | 231 | 听 | 听 | 听 | 12,850 | 听 | 听 | 听 | 3,454 | 听 |
| Adjusted EBITDA | $ | 114,018 | 听 | 听 | $ | 108,357 | 听 | 听 | $ | 225,784 | 听 | 听 | $ | 206,647 | 听 |
| 听 | 听 | 听 | 听 | 听 | 听 | 听 | 听 | ||||||||
| Net income | $ | 50,523 | 听 | 听 | $ | 53,043 | 听 | 听 | $ | 97,265 | 听 | 听 | $ | 97,834 | 听 |
| Intangible asset amortization expense | 听 | 9,297 | 听 | 听 | 听 | 8,604 | 听 | 听 | 听 | 18,394 | 听 | 听 | 听 | 17,213 | 听 |
| Stock-based incentive compensation expense | 听 | 10,712 | 听 | 听 | 听 | 7,608 | 听 | 听 | 听 | 19,513 | 听 | 听 | 听 | 17,213 | 听 |
| Restructuring, acquisition, integration and other | 听 | 3,045 | 听 | 听 | 听 | 231 | 听 | 听 | 听 | 12,850 | 听 | 听 | 听 | 3,454 | 听 |
| Total pre-tax adjustments | 听 | 23,054 | 听 | 听 | 听 | 16,443 | 听 | 听 | 听 | 50,757 | 听 | 听 | 听 | 37,880 | 听 |
| Tax adjustments (1) | 听 | (6,109 | ) | 听 | 听 | (4,546 | ) | 听 | 听 | (13,451 | ) | 听 | 听 | (9,134 | ) |
| Adjusted net income | $ | 67,468 | 听 | 听 | $ | 64,940 | 听 | 听 | $ | 134,571 | 听 | 听 | $ | 126,580 | 听 |
| 听 | 听 | 听 | 听 | 听 | 听 | 听 | 听 | ||||||||
| Earnings per share, diluted | $ | 0.31 | 听 | 听 | $ | 0.30 | 听 | 听 | $ | 0.59 | 听 | 听 | $ | 0.56 | 听 |
| Adjusted earnings per share, diluted | $ | 0.41 | 听 | 听 | $ | 0.37 | 听 | 听 | $ | 0.81 | 听 | 听 | $ | 0.72 | 听 |
| Weighted average common shares outstanding, diluted | 听 | 164,133 | 听 | 听 | 听 | 174,090 | 听 | 听 | 听 | 165,402 | 听 | 听 | 听 | 174,831 | 听 |
| 听 | 听 | 听 | 听 | 听 | 听 | 听 | 听 | 听 | 听 | 听 | 听 | 听 | 听 | 听 | 听 |
(1) Tax adjustments for the three and six months ended June 30, 2025 and 2024 includes the estimated income tax effect on non-GAAP adjustments based on the effective tax rate
FAQ
What were Option Care Health's (OPCH) Q2 2025 earnings results?
What is Option Care Health's (OPCH) full-year 2025 guidance?
How much stock did OPCH repurchase in Q2 2025?
What was Option Care Health's Q2 2025 EBITDA?
What was OPCH's operating cash flow in Q2 2025?
